For many medical conditions, the FAA is primarily concerned with whether your condition is properly diagnosed, appropriately treated, and adequately controlled. The FAA expects medical conditions to be managed according to current, generally accepted medical standards. That means using established, evidence-based treatments rather than experimental therapies or outdated approaches that have fallen out of favor with modern medical practice.

Having said that, there is another important part of FAA medical certification that pilots often overlook.

While the FAA evaluates you as an individual, it also evaluates the risks associated with your medical condition and treatment against what is known about people with similar conditions in the general population.

The Detailed Clinical Progress Note: Your Most Important Supporting Document

One of the best ways to demonstrate appropriate medical management is through a current detailed clinical progress note (DCPN) from your treating physician.

We have previously discussed why detailed clinical progress notes are so important for FAA medical certification.

A useful DCPN generally includes:

• The specific diagnosis and relevant medical history.
• Current symptoms, or documentation that symptoms have resolved.
• Relevant physical examination findings.
• Results of appropriate diagnostic testing.
• Current medications, treatments, and any side effects.
• The physician’s assessment of disease control and stability.
• The ongoing treatment and follow-up plan.
• Relevant complications, functional limitations, or risk factors.

This information allows the FAA to determine not only whether you are receiving treatment, but also whether that treatment is working. A letter is merely an opinion whereas a detailed clinical progress note provides evidence that supports the medical conclusion provided.

Not Every Condition Can Be Immediately Certified

There are important limitations to this general approach. Federal aviation regulations identify a number of specifically disqualifying medical conditions. These include certain cardiovascular, neurological, psychiatric, and substance-related conditions.

When a pilot has one of these conditions, an Aviation Medical Examiner cannot simply issue a medical certificate because the pilot appears healthy or has a favorable report from a treating physician. However, a disqualifying diagnosis does not necessarily mean a permanent end to flying.

Many pilots with these conditions can ultimately qualify for a Special Issuance Authorization after providing sufficient medical evidence demonstrating that their condition is appropriately managed and that their overall aeromedical risk is acceptable.

Even excellent medical management does not eliminate every certification limitation. Certain diagnoses carry risks that cannot be adequately assessed through a routine examination, and some conditions may remain incompatible with medical certification. To understand why, we need to look beyond the individual pilot.

The FAA Evaluates Individuals Using Population-Based Risk

Your treating physician is primarily concerned with your individual health. The FAA is also concerned with the probability that your condition could cause impairment or incapacitation during flight. To evaluate that probability, the FAA relies on medical research, clinical outcomes, and the known risks associated with particular diagnoses and treatments. These are population based risks.

Consider a hypothetical pilot who has experienced a significant brain injury or undergone a particular type of brain surgery. Suppose medical research demonstrates that patients with this type of injury or procedure have a 10% risk of developing a seizure during the first year. That means 90% of those patients will not experience a seizure during that period. But the FAA cannot reliably determine which individual pilot will fall into the 90% who remain seizure-free and which will fall into the 10% who develop a seizure.

The pilot may feel completely normal. Neurological examinations may be reassuring. Recovery may be excellent. However, none of those findings necessarily eliminates the underlying statistical risk.

This is why certain neurological conditions require observation periods before the FAA will consider medical certification. As time passes without complications, the probability of a subsequent event may decrease sufficiently to permit further consideration.

The FAA must balance the circumstances of the individual pilot against the potential consequences of a sudden medical event in the national airspace system. 

Mental Health: How Population Risk Has Changed FAA Policy

One of the clearest examples of population-based risk assessment influencing FAA medical certification is the significant evolution of the FAA’s mental health disposition policies over the last several years. As we discussed in our article on Pilot Mental Health and FAA Medical Certification, the FAA has made substantial changes to how it evaluates certain psychiatric diagnoses.

These changes reflect an increasingly nuanced understanding that not all mental health conditions carry the same risks. For example, a pilot with a remote history of mild anxiety or depression who has been asymptomatic and has not required significant treatment for several years generally presents a different risk profile from a pilot with recurrent major depressive disorder, recent severe symptoms, psychiatric hospitalization, or a history of suicidal behavior.

The diagnosis, severity of symptoms, recurrence history, treatment requirements, and time since the last episode all matter in the risk profile. This risk stratification helped support the FAA’s Anxiety, Depression, and Related Conditions disposition protocol.

Under this protocol, certain pilots with qualifying histories of relatively mild mental health conditions may receive medical certification directly from their AME when they satisfy the applicable criteria. By contrast, a diagnosis such as major depressive disorder may warrant substantially greater scrutiny because of its association with recurrent illness, functional impairment, and increased suicide risk compared with the general population.

The risks are not identical for every person with major depressive disorder. They vary considerably based on disease severity, recurrence, comorbidities, treatment response, and other clinical factors. But the diagnosis heightens the overall level of concern resulting in a need for increased scrutiny to see exactly where the individual’s risk is compared to the population model.

Coronary Artery Disease: Recovery Does Not Eliminate Future Risk

Cardiovascular disease provides another useful example. Following appropriate treatment after a heart attack, which may include coronary stenting or bypass surgery, the pilot may make an excellent recovery. The pilot may have no chest pain, normal exercise tolerance, and reassuring results from subsequent cardiac testing. From a clinical perspective, the pilot may be doing extremely well.

However, a history of myocardial infarction establishes that the pilot has coronary artery disease and has already experienced a significant cardiovascular event. Compared with an otherwise similar person without known coronary artery disease, that pilot generally has an increased risk of future cardiovascular events.

Modern treatments have significantly improved outcomes. Coronary stents, appropriate medications, lipid management, blood pressure control, and lifestyle modifications can substantially reduce the risk of recurrent events. But reducing risk is not the same as eliminating it. The FAA therefore considers not only whether the pilot has recovered from the initial heart attack, but also the likelihood of another event occurring during the period of medical certification.

This is why the FAA may require a period of recovery and observation, cardiovascular testing, specialist evaluations, and ongoing surveillance before granting certification through the Special Issuance process.

Once again, the FAA is evaluating the individual pilot in the context of what medical research tells us about patients with similar cardiovascular disease.

Why Appropriate Treatment and Good Documentation Matter

These examples highlight two separate but closely related parts of FAA medical certification. The first is the condition itself. Certain diagnoses carry known risks of recurrence, progression, impairment, or sudden incapacitation, even when the patient feels perfectly healthy.

The second is how effectively that condition is being managed. Appropriate medical treatment can substantially alter the risk profile associated with many conditions. Modern medical therapies, objective testing, and ongoing surveillance provide the FAA with evidence that the risks are being reduced.

This is where the detailed clinical progress note becomes particularly valuable. A DCPN does not eliminate the risks associated with a diagnosis. It does, however, help demonstrate where the individual pilot falls within the broader spectrum of patients with that condition.

For example, two pilots may have the same diagnosis, but one has poorly controlled symptoms, inconsistent treatment, and limited follow-up. The other has stable disease, appropriate medication management, reassuring objective testing, and regular specialist care.

Individual Medical Care, Population-Based Risk

For many conditions, the FAA’s primary objective is to establish that the pilot has received an appropriate diagnosis, is being treated according to modern medical standards, and has demonstrated adequate control and stability.

A current, detailed clinical progress note is often the most effective way to communicate that information. But pilots must also recognize that medical certification involves more than an assessment of their current health.

The FAA evaluates you as an individual, but it evaluates your diagnosis, treatment, and likelihood of future complications against the known risks observed in larger patient populations.

A pilot may be completely asymptomatic and be receiving excellent care, yet still have a statistically elevated risk of an event that could compromise flight safety.

Conversely, a diagnosis that once presented a significant certification obstacle may become manageable as medical treatments improve, research evolves, and better evidence allows the FAA to distinguish between higher-risk and lower-risk patients. This is what allowed insulin dependent diabetes to be eligible for first class medical certification.

This is the fundamental balance of aeromedical certification: recognizing the circumstances of the individual while protecting the safety of the national airspace system.

At Wingman Med, we help pilots understand how the FAA evaluates their medical conditions, what documentation is needed, and how to prepare for the certification process.

Prepare for your FAA medical like a check ride.

The better you understand the standards, the risks, and the documentation requirements before your examination, the better prepared you will be to navigate the FAA medical certification process.